Advertisement

Topics

Positive results for infliximab and trastuzumab biosimilars

05:06 EDT 13 Jul 2018 | Generics and Biosimilars Initiative

Celltrion Healthcare (Celltrion) and Samsung Bioepis have both announced positive results for their infliximab and trastuzumab biosimilars, respectively.

Original Article: Positive results for infliximab and trastuzumab biosimilars

NEXT ARTICLE

More From BioPortfolio on "Positive results for infliximab and trastuzumab biosimilars"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...